Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state 13C CPMAS NMR spectroscopy

Tommi Virtanen (Corresponding Author), Sirkka L. Maunu

Research output: Contribution to journalArticleScientificpeer-review

32 Citations (Scopus)

Abstract

Active pharmaceutical ingredients (API) often crystallise in several forms with significant differences in their physical properties. In pharmaceutical applications it is very important to be able to identify these polymorphs during drug manufacturing and storaging, also quantitative information about polymorphs is often required. Solid state 13C cross-polarisation (CP), magic angle spinning (MAS), nuclear magnetic resonance (NMR) spectroscopy was utilised in studying polymorphisity of an API with two polymorphic forms. Quantitative information was obtained from polymorphic mixtures, and a formulated product was also studied in order to determine the possibility of distinguishing between the two polymorphs in a low-dose formulation. Quantitative data was obtained using two methods: integration of signals from the dipolar dephased spectra, and a chemometric method known as Direct Exponential Curve Resolution Algorithm (DECRA). We concluded that the two polymorphs are easily identifiable based on their spectral differences. Quantitative results showed reasonable accuracy, and while identification of the polymorph present in formulation was not possible, traces of the API are detectable in as low dosage as 0.7% by weight using solid state NMR methods.

Original languageEnglish
Pages (from-to)18-25
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume394
Issue number1-2
DOIs
Publication statusPublished - Jul 2010
MoE publication typeA1 Journal article-refereed

Fingerprint

Magnetic Resonance Spectroscopy
Pharmaceutical Preparations
Weights and Measures

Keywords

  • DECRA
  • Polymorphism
  • Quantitation
  • Solid state NMR

Cite this

@article{1bb052caaa1249d3a2e07905a93c89a0,
title = "Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state 13C CPMAS NMR spectroscopy",
abstract = "Active pharmaceutical ingredients (API) often crystallise in several forms with significant differences in their physical properties. In pharmaceutical applications it is very important to be able to identify these polymorphs during drug manufacturing and storaging, also quantitative information about polymorphs is often required. Solid state 13C cross-polarisation (CP), magic angle spinning (MAS), nuclear magnetic resonance (NMR) spectroscopy was utilised in studying polymorphisity of an API with two polymorphic forms. Quantitative information was obtained from polymorphic mixtures, and a formulated product was also studied in order to determine the possibility of distinguishing between the two polymorphs in a low-dose formulation. Quantitative data was obtained using two methods: integration of signals from the dipolar dephased spectra, and a chemometric method known as Direct Exponential Curve Resolution Algorithm (DECRA). We concluded that the two polymorphs are easily identifiable based on their spectral differences. Quantitative results showed reasonable accuracy, and while identification of the polymorph present in formulation was not possible, traces of the API are detectable in as low dosage as 0.7{\%} by weight using solid state NMR methods.",
keywords = "DECRA, Polymorphism, Quantitation, Solid state NMR",
author = "Tommi Virtanen and Maunu, {Sirkka L.}",
year = "2010",
month = "7",
doi = "10.1016/j.ijpharm.2010.04.017",
language = "English",
volume = "394",
pages = "18--25",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1-2",

}

Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state 13C CPMAS NMR spectroscopy. / Virtanen, Tommi (Corresponding Author); Maunu, Sirkka L.

In: International Journal of Pharmaceutics, Vol. 394, No. 1-2, 07.2010, p. 18-25.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state 13C CPMAS NMR spectroscopy

AU - Virtanen, Tommi

AU - Maunu, Sirkka L.

PY - 2010/7

Y1 - 2010/7

N2 - Active pharmaceutical ingredients (API) often crystallise in several forms with significant differences in their physical properties. In pharmaceutical applications it is very important to be able to identify these polymorphs during drug manufacturing and storaging, also quantitative information about polymorphs is often required. Solid state 13C cross-polarisation (CP), magic angle spinning (MAS), nuclear magnetic resonance (NMR) spectroscopy was utilised in studying polymorphisity of an API with two polymorphic forms. Quantitative information was obtained from polymorphic mixtures, and a formulated product was also studied in order to determine the possibility of distinguishing between the two polymorphs in a low-dose formulation. Quantitative data was obtained using two methods: integration of signals from the dipolar dephased spectra, and a chemometric method known as Direct Exponential Curve Resolution Algorithm (DECRA). We concluded that the two polymorphs are easily identifiable based on their spectral differences. Quantitative results showed reasonable accuracy, and while identification of the polymorph present in formulation was not possible, traces of the API are detectable in as low dosage as 0.7% by weight using solid state NMR methods.

AB - Active pharmaceutical ingredients (API) often crystallise in several forms with significant differences in their physical properties. In pharmaceutical applications it is very important to be able to identify these polymorphs during drug manufacturing and storaging, also quantitative information about polymorphs is often required. Solid state 13C cross-polarisation (CP), magic angle spinning (MAS), nuclear magnetic resonance (NMR) spectroscopy was utilised in studying polymorphisity of an API with two polymorphic forms. Quantitative information was obtained from polymorphic mixtures, and a formulated product was also studied in order to determine the possibility of distinguishing between the two polymorphs in a low-dose formulation. Quantitative data was obtained using two methods: integration of signals from the dipolar dephased spectra, and a chemometric method known as Direct Exponential Curve Resolution Algorithm (DECRA). We concluded that the two polymorphs are easily identifiable based on their spectral differences. Quantitative results showed reasonable accuracy, and while identification of the polymorph present in formulation was not possible, traces of the API are detectable in as low dosage as 0.7% by weight using solid state NMR methods.

KW - DECRA

KW - Polymorphism

KW - Quantitation

KW - Solid state NMR

UR - http://www.scopus.com/inward/record.url?scp=77953717797&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2010.04.017

DO - 10.1016/j.ijpharm.2010.04.017

M3 - Article

C2 - 20416365

AN - SCOPUS:77953717797

VL - 394

SP - 18

EP - 25

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1-2

ER -